48 related articles for article (PubMed ID: 10841223)
1. Upregulation of the Bcl-2 family of proteins in end stage heart failure.
Latif N; Khan MA; Birks E; O'Farrell A; Westbrook J; Dunn MJ; Yacoub MH
J Am Coll Cardiol; 2000 Jun; 35(7):1769-77. PubMed ID: 10841223
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cardiomyocyte DNA damage and cell death by the type 2A protein phosphatase regulatory protein alpha4.
Cowan J; Longman MR; Snabaitis AK
Sci Rep; 2021 Mar; 11(1):6293. PubMed ID: 33737606
[TBL] [Abstract][Full Text] [Related]
3. Dhcr24 activates the PI3K/Akt/HKII pathway and protects against dilated cardiomyopathy in mice.
Dong W; Guan FF; Zhang X; Gao S; Liu N; Chen W; Zhang LF; Lu D
Animal Model Exp Med; 2018 Mar; 1(1):40-52. PubMed ID: 30891546
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Sestrin2 Increases Lipopolysaccharide-Induced Oxidative Stress, Apoptosis, and Fibrotic Reactions in H9c2 Cells and Heart Tissues of Mice via an AMPK-Dependent Mechanism.
Hwang HJ; Kim JW; Chung HS; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
Mediators Inflamm; 2018; 2018():6209140. PubMed ID: 30116150
[TBL] [Abstract][Full Text] [Related]
5. A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
Bayoumi AS; Park KM; Wang Y; Teoh JP; Aonuma T; Tang Y; Su H; Weintraub NL; Kim IM
J Mol Cell Cardiol; 2018 Jan; 114():72-82. PubMed ID: 29122578
[TBL] [Abstract][Full Text] [Related]
6. Identifying differential miR and gene consensus patterns in peripheral blood of patients with cardiovascular diseases from literature data.
Šatrauskienė A; Navickas R; Laucevičius A; Huber HJ
BMC Cardiovasc Disord; 2017 Jun; 17(1):173. PubMed ID: 28666417
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and promotion of cardiac myocyte apoptosis.
Andréka P; Tran T; Webster KA; Bishopric NH
Mol Cell Biochem; 2004 Aug; 263(1):35-53. PubMed ID: 27520664
[TBL] [Abstract][Full Text] [Related]
8. Chronic heart failure: Ca(2+), catabolism, and catastrophic cell death.
Cho GW; Altamirano F; Hill JA
Biochim Biophys Acta; 2016 Apr; 1862(4):763-777. PubMed ID: 26775029
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Dynamics and Heart Failure.
Knowlton AA; Liu TT
Compr Physiol; 2015 Dec; 6(1):507-26. PubMed ID: 26756641
[TBL] [Abstract][Full Text] [Related]
10. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
Chaudhari U; Nemade H; Wagh V; Gaspar JA; Ellis JK; Srinivasan SP; Spitkovski D; Nguemo F; Louisse J; Bremer S; Hescheler J; Keun HC; Hengstler JG; Sachinidis A
Arch Toxicol; 2016 Nov; 90(11):2763-2777. PubMed ID: 26537877
[TBL] [Abstract][Full Text] [Related]
11. Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression.
Bogomolovas J; Brohm K; Čelutkienė J; Balčiūnaitė G; Bironaitė D; Bukelskienė V; Daunoravičus D; Witt CC; Fielitz J; Grabauskienė V; Labeit S
Biomed Res Int; 2015; 2015():273936. PubMed ID: 25961010
[TBL] [Abstract][Full Text] [Related]
12. Microglial cell activation increases saturated and decreases monounsaturated fatty acid content, but both lipid species are proinflammatory.
Button EB; Mitchell AS; Domingos MM; Chung JH; Bradley RM; Hashemi A; Marvyn PM; Patterson AC; Stark KD; Quadrilatero J; Duncan RE
Lipids; 2014 Apr; 49(4):305-16. PubMed ID: 24473753
[TBL] [Abstract][Full Text] [Related]
13. Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis.
Ren R; Oakley RH; Cruz-Topete D; Cidlowski JA
Endocrinology; 2012 Nov; 153(11):5346-60. PubMed ID: 22989630
[TBL] [Abstract][Full Text] [Related]
14. Morphological and molecular changes of the myocardium after left ventricular mechanical support.
Baba HA; Wohlschlaeger J
Curr Cardiol Rev; 2008 Aug; 4(3):157-69. PubMed ID: 19936192
[TBL] [Abstract][Full Text] [Related]
15. Having a change of heart: reversing the suicidal proclivities of cardiac myocytes.
Dorn GW
Trans Am Clin Climatol Assoc; 2009; 120():189-98. PubMed ID: 19768177
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling.
Dorn GW
Cardiovasc Res; 2009 Feb; 81(3):465-73. PubMed ID: 18779231
[TBL] [Abstract][Full Text] [Related]
17. A synopsis of research in cardiac apoptosis and its application to congestive heart failure.
Khoynezhad A; Jalali Z; Tortolani AJ
Tex Heart Inst J; 2007; 34(3):352-9. PubMed ID: 17948087
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart.
Friehs I; Barillas R; Vasilyev NV; Roy N; McGowan FX; del Nido PJ
Circulation; 2006 Jul; 114(1 Suppl):I290-5. PubMed ID: 16820588
[TBL] [Abstract][Full Text] [Related]
19. Morphological aspects of apoptosis in heart diseases.
Takemura G; Fujiwara H
J Cell Mol Med; 2006; 10(1):56-75. PubMed ID: 16563222
[TBL] [Abstract][Full Text] [Related]
20. Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.
DeBiasi RL; Robinson BA; Sherry B; Bouchard R; Brown RD; Rizeq M; Long C; Tyler KL
J Virol; 2004 Oct; 78(20):11040-50. PubMed ID: 15452224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
